LNTH · NASDAQ · Drug Manufacturers - Specialty & Generic

Lantheus (LNTH)

Commercializes PET radiodiagnostics and ultrasound-enhancing agents for prostate cancer, amyloid, and cardiac imaging.

$99.94
vs last close−0.06 (−0.07%)